Page results
-
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCLH, UCL and the Francis Crick Institute.
-
This page tells you about having a Non-Tunnelled CVC Line Insertion (Vascath). This page is for those patients who have been referred to Interventional Radiology.
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Interventional Radiology team.
-
This booklet tells you about having a Vortex® Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Vascular Access team.
-
This page is for patients who have been referred by their GP to a gynaecology specialist because their symptoms need further tests.
-
A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
At UCLH we run seasonal COVID-19 vaccination clinics from our Hospital Hub within UCH. Vaccinations are available to members of the eligible public as well as UCLH patients.
File results
-
FOI/2022/0251 - Antenatal appointments
-
FOI/2022/0252 - Translation services
-
FOI/2022/0253 - TB patient demographics
-
FOI/2022/0254 - Patient treatment/ surgery
-
FOI/2022/0263 - Rheumatology prescriptions
-
FOI/2022/0267 - Performance data for the CCG2 CQUIN - Antibiotic prescribing for UTI in adults aged 16+
-
FOI/2022/0270 - Local care record/ shared care record implementation
-
FOI/2022/0274 - Patient treatment for various conditions
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0276 - Biologic medicines within dermatology